Sibo Tian
2022-04-25
Disease
PCG registry
Abatary Discription
To evaluate clinical outcomes of patients with thymic malignancies treated with proton therapy (last reviewed through early 2017, now with dosimetric/DVH data) specifically looking at disease/survival endpoints, toxicity, patterns of failure, and dosimetry correlates